155 related articles for article (PubMed ID: 34476633)
1. Clinical outcomes and prognostic factors for esophageal cancer in patients aged 80 years or older who were treated with definitive radiotherapy and chemoradiotherapy.
Takahashi N; Umezawa R; Kishida K; Yamamoto T; Ishikawa Y; Takeda K; Suzuki Y; Kawabata K; Teramura S; Jingu K
Esophagus; 2022 Jan; 19(1):129-136. PubMed ID: 34476633
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy.
Du XX; Yu R; Wang ZF; Du DC; Liu QY; Wang RM; Kang SR; Yang H
Bosn J Basic Med Sci; 2019 May; 19(2):186-194. PubMed ID: 30877837
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy.
Qiu J; Yang J; Yu Y; Wang Z; Lin H; Ke D; Zheng H; Li J; Yao Q
BMC Cancer; 2023 Jun; 23(1):597. PubMed ID: 37380982
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the Geriatric Nutritional Risk Index in Patients Exceeding 70 Years Old with Esophageal Squamous Cell Carcinoma.
Wang Y; Wang L; Fang M; Li J; Song T; Zhan W; Xu H
Nutr Cancer; 2020; 72(4):620-626. PubMed ID: 31390885
[TBL] [Abstract][Full Text] [Related]
5. The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin.
Fujiwara Y; Sato Y; Hayashi N; Fukuda N; Wang X; Nakano K; Ohmoto A; Urasaki T; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takahashi S
J Geriatr Oncol; 2023 Jun; 14(5):101523. PubMed ID: 37229881
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
Song T; Du D; Zhang X; Fang M; Wu S
Dis Esophagus; 2017 Sep; 30(9):1-10. PubMed ID: 28859362
[TBL] [Abstract][Full Text] [Related]
8. Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis.
Luo HS; Xu HY; Du ZS; Li XY; Wu SX; Huang HC; Lin LX
Radiat Oncol; 2019 May; 14(1):74. PubMed ID: 31046792
[TBL] [Abstract][Full Text] [Related]
9. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
[TBL] [Abstract][Full Text] [Related]
10. Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
Mou Y; Liang P; Cheng X; He X; Zhang J; Liu L; Liu Q
BMC Cancer; 2024 May; 24(1):646. PubMed ID: 38802765
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
[No Abstract] [Full Text] [Related]
12. Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study.
Guler OC; Oymak E; Yazici G; Akagunduz OO; Cetinayak O; Erpolat P; Aksoy A; Duzova M; Yildirim BA; Kurt M; Canyilmaz E; Yavas G; Akyurek S; Oksuz DC; Saglam EK; Celik OK; Ozyar E; Cengiz M; Onal C
Oncol Res; 2023; 31(3):299-306. PubMed ID: 37305394
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Treatment Outcomes of the Elder Patients with Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma with Definitive Chemoradiotherapy or Radiotherapy.
Liu J; Li Y; Chen Y; Jiang X; Yu H; Yan S
Contrast Media Mol Imaging; 2022; 2022():3678441. PubMed ID: 35924070
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
15. Geriatric nutritional risk index predicts cancer prognosis in patients with local advanced rectal cancer undergoing chemoradiotherapy followed by curative surgery.
Ide S; Okugawa Y; Omura Y; Yamamoto A; Ichikawa T; Kitajima T; Shimura T; Imaoka H; Fujikawa H; Yasuda H; Yokoe T; Okita Y; Ohi M; Toiyama Y
World J Surg Oncol; 2021 Jan; 19(1):34. PubMed ID: 33516219
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
17. Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
Smit JK; Muijs CT; Burgerhof JG; Paardekooper G; Timmer PR; Muller K; Woutersen D; Mul VE; Beukema JC; Hospers GA; van Dijk BA; Langendijk JA; Plukker JT
Ann Surg Oncol; 2013 Jun; 20(6):1985-92. PubMed ID: 23274534
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy and radiotherapy alone in patients with esophageal cancer aged 80 years or older based on the Comprehensive Registry of Esophageal Cancer in Japan.
Jingu K; Numasaki H; Toh Y; Nemoto K; Uno T; Doki Y; Matsubara H
Esophagus; 2020 Jul; 17(3):223-229. PubMed ID: 32088786
[TBL] [Abstract][Full Text] [Related]
19. Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.
Tang QN; Qiu HZ; Sun XQ; Guo SS; Liu LT; Wen YF; Liu SL; Xie HJ; Liang YJ; Sun XS; Li XY; Yan JJ; Yang JH; Wen DX; Guo L; Tang LQ; Chen QY; Mai HQ
Ann Transl Med; 2021 Apr; 9(7):532. PubMed ID: 33987230
[TBL] [Abstract][Full Text] [Related]
20. [The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma].
Ni WJ; Deng W; Xiao ZF; Zhou ZM; Wang X; Chen DF; Feng QF; Liang J; Lyu JM; Bi N; Deng L; Zhang T; Wang WQ; Xue Q; Gao SG; Mu JW; Mao YS; Wang DL; Zhao J; Gao YS; Huang JF; Tan FW; Zhao L; Lyu F; Zhang GC
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):295-302. PubMed ID: 31014056
[No Abstract] [Full Text] [Related]
[Next] [New Search]